HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beiyun Chen Selected Research

Pathologic Complete Response

11/2022Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial.
11/2021Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
1/2020Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beiyun Chen Research Topics

Disease

33Breast Neoplasms (Breast Cancer)
11/2022 - 08/2003
27Neoplasms (Cancer)
11/2022 - 10/2002
3Pathologic Complete Response
11/2022 - 01/2020
3Residual Neoplasm
01/2022 - 03/2006
3Carcinoma (Carcinomatosis)
12/2019 - 12/2004
2Neoplasm Metastasis (Metastasis)
04/2006 - 07/2003
2Colonic Neoplasms (Colon Cancer)
04/2006 - 07/2003
2Colorectal Neoplasms (Colorectal Cancer)
04/2006 - 10/2005
1Acquired Immunodeficiency Syndrome (AIDS)
04/2024
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2022
1Cardiotoxicity
04/2022
1Adenocarcinoma of Lung
08/2017
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017
1Mastodynia
01/2017
1Amyloidosis
02/2013
1Fat Necrosis
10/2012
1Disease Progression
05/2012
1Osteosarcoma (Osteogenic Sarcoma)
12/2010
1Leukemia
12/2010
1Adenoma (Adenomas)
04/2006
1Philadelphia Chromosome
03/2006
1Transitional Cell Carcinoma
12/2004
1Ovarian Neoplasms (Ovarian Cancer)
12/2004

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
08/2017 - 07/2003
9Trastuzumab (Herceptin)FDA Link
07/2021 - 12/2010
8ParaffinIBA
12/2010 - 07/2003
7ErbB Receptors (EGF Receptor)IBA
03/2015 - 08/2005
7Formaldehyde (Formol)FDA Link
12/2010 - 08/2003
6human ERBB2 proteinIBA
01/2018 - 01/2010
4Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2003
4Estrogen ReceptorsIBA
08/2017 - 12/2010
3Hormones (Hormone)IBA
11/2022 - 10/2013
3Monoclonal AntibodiesIBA
12/2019 - 04/2006
3Messenger RNA (mRNA)IBA
03/2015 - 08/2005
2Lapatinib (GW572016)FDA Link
07/2021 - 01/2020
2Progesterone Receptors (Progesterone Receptor)IBA
08/2017 - 04/2005
2AntibodiesIBA
04/2006 - 08/2005
2Ligases (Synthetase)IBA
09/2003 - 07/2003
1Polymethyl Methacrylate (Sol)IBA
04/2024
1AnthracyclinesIBA
04/2022
1IronIBA
04/2022
1pixantrone (BBR 2778)IBA
04/2022
1Mitoxantrone (Novantrone)FDA LinkGeneric
04/2022
1AnthraquinonesIBA
04/2022
1cixutumumabIBA
07/2021
1Capecitabine (Xeloda)FDA Link
07/2021
1Docetaxel (Taxotere)FDA Link
01/2020
1Carboplatin (JM8)FDA LinkGeneric
01/2020
1Androgen Receptors (Androgen Receptor)IBA
08/2017
1Capsules (Microcapsules)IBA
01/2017
1Epidermal Growth Factor (EGF)IBA
02/2014
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
06/2013
1Immunoglobulins (Immunoglobulin)IBA
02/2013
1Amyloid (Amyloid Fibrils)IBA
02/2013
1Transforming Growth Factor beta (TGF-beta)IBA
05/2012
1AgarIBA
05/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2012
1RadiopharmaceuticalsIBA
04/2012
1Coloring Agents (Dyes)IBA
02/2012
1Type II DNA Topoisomerases (Topoisomerase II)IBA
12/2010
1RNA (Ribonucleic Acid)IBA
12/2010
1SurvivinIBA
12/2010
1Wnt-5a ProteinIBA
12/2010
1GRB7 Adaptor ProteinIBA
12/2010
1Cyclin A2IBA
12/2010
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2006
1Growth Factor ReceptorsIBA
10/2005
1Cetuximab (Erbitux)FDA Link
10/2005
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2005
1Estrogens (Estrogen)FDA Link
04/2005
1ProgesteroneFDA LinkGeneric
04/2005
1AntigensIBA
10/2002

Therapy/Procedure

12Therapeutics
11/2022 - 10/2005
5Neoadjuvant Therapy
11/2022 - 04/2012
5Drug Therapy (Chemotherapy)
11/2021 - 12/2011
1Investigational Therapies (Experimental Therapy)
11/2021
1Breast Implants (Breast Implant)
01/2017
1Combination Drug Therapy (Combination Chemotherapy)
03/2015
1Operative Surgical Procedures
10/2012
1Adjuvant Chemotherapy
12/2011